SmithRx is a a next-generation PBM company.
Venrock leads pharmacy startup’s $20m refill
March 10, 2022
SmithRx filled a $20 million Series B funding round led by leading Silicon Valley firm Venrock with support from Founders Fund, bringing the PBM startup’s valuation to $100 million, Venrock partner Bryan Roberts tells Axios exclusively. Axios
Return to Companies